Meitav Dash Investments LTD Evogene Ltd. Transaction History

Meitav Dash Investments LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$2.41 - $5.63 $46,917 - $109,604	-19,468 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$0.97 - $4.08 $241 - $1,015	-249 Reduced 1.26%	19,468 $77,000
Q4 2019 Feb 10, 2020	SELL	$1.29 - $1.69 $67,252 - $88,106	-52,134 Reduced 72.56%	19,717 $30,000
Q3 2019 Nov 14, 2019	BUY	$1.37 - $1.7 $24,810 - $30,787	18,110 Added 33.7%	71,851 $121,000
Q2 2019 Aug 14, 2019	BUY	$1.4 - $2.47 $35,308 - $62,293	25,220 Added 88.43%	53,741 $87,000
Q1 2019 May 13, 2019	BUY	$1.83 - $2.38 $16,111 - $20,953	8,804 Added 44.65%	28,521 $51,000
Q4 2018 Feb 13, 2019	SELL	$1.98 - $3.01 $17,732 - $26,957	-8,956 Reduced 31.23%	19,717 $39,000
Q2 2018 Aug 14, 2018	BUY	$2.84 - $3.29 $25,003 - $28,965	8,804 Added 44.31%	28,673 $151,000
Q4 2017 Feb 15, 2018	BUY	$3.07 - $4.68 $60,997 - $92,986	19,869	19,869 $61,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $69.6M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.